Gilead Sciences Inc buy dimontalban
Start price
08.11.14
/
50%
€85.85
Target price
01.04.15
€120.00
Performance (%)
4.12%
End price
01.04.15
€89.39
Summary
This prediction ended on 01.04.15 with a price of €89.39. The BUY prediction by dimontalban finished with a performance of 4.12%. dimontalban has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Gilead Sciences Inc | -0.800% | -0.800% | -6.719% | 9.921% |
iShares Core DAX® | 3.054% | -1.396% | 15.789% | 12.675% |
iShares Nasdaq 100 | 4.389% | -5.391% | 29.906% | 39.325% |
iShares Nikkei 225® | 5.386% | -3.105% | 16.065% | 8.150% |
iShares S&P 500 | 2.955% | -3.011% | 25.903% | 37.650% |
Comments by dimontalban for this prediction
In the thread Gilead Sciences Inc diskutieren
HIV Positiv
Die neue 1 Tabletten Therapie gegen HIV verspricht ein weiteres Mrd. Geschäft zu werden. Der Anstieg sollte sich ähnlich spektakulär fortsetzen wie bisher.
(Stop Loss Kurs erreicht)
Stopped prediction by dimontalban for Gilead Sciences Inc
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€74.46
21.04.20
21.04.20
€130.00
23.08.20
23.08.20
-24.78%
23.08.20
23.08.20